Pharma Commercial Analytics Outsourcing: What to Hand Over, What It Costs and How to Choose a Partner

Pharma commercial analytics outsourcing in one paragraph

Pharma commercial analytics outsourcing means handing defined, repeatable analytics work, such as data processing, weekly brand and field reporting, incentive compensation calculations and targeting refreshes, to an external partner, often with an offshore team, while your own people keep the questions, the decisions and the relationships with brand and sales leaders. It works when the scope is written down, the partner can legally access your licensed data, and the contract measures accuracy and timeliness rather than hours. It fails when a company outsources a mess and expects the vendor to sort out ownership as well as the work.

Most of what ranks for this topic is either a decade old or a vendor list. This guide is written for the commercial operations or analytics lead deciding now: what to hand over, which delivery model fits, what the money looks like with sourced benchmarks, the data licensing rules that trip up most transitions, the SLAs to write in, and when outsourcing is the wrong call.

What to outsource and what to keep in-house

Outsource

Work with clear inputs, clear logic and a fixed cadence moves well. ZS consultants made the same split in PharmExec back in 2015: keep a lean internal team on strategic insight and move detailed data work and modelling to a cost-effective partner. It still holds.

Keep

Anything that decides money, people or strategy, or that needs a seat in the room with brand and sales leadership, stays with you. A partner can prepare the analysis; your team owns the answer.

Share

Launch analytics, ad hoc deep dives and new data source onboarding need your context and the partner's capacity. Run them as small projects with a named owner on each side rather than as part of the steady-state service.

Delivery models compared

Staff augmentation

Analysts join your team and take direction from your managers. Fast to start and flexible, but quality depends on your own management time, and knowledge leaves when the person does.

Project

A defined build such as a commercial data model, an IC engine or a launch dashboard, delivered against milestones. Clear cost, but someone still has to run the thing once the project ends.

Managed service

The partner owns delivery of agreed outputs, for example the weekly field report by 9am Monday Eastern, with service levels, a named lead and a team behind them. The model most mid-sized pharma companies end up with for steady-state reporting.

Captive centre

Large companies such as AstraZeneca, Eli Lilly and Novartis run their own centres in India. It gives full control, but needs scale, a legal entity and years of management attention, so it rarely fits a company with one or two brands.

What does pharma analytics outsourcing cost?

No independent source publishes vendor rates for pharma commercial analytics, and most firms quote only after scoping. What is published is what the underlying people cost, which sets the floor any vendor price is built on.

At any exchange rate seen in 2025 or 2026, Rs 578,578 is under $7,000 a year, a small fraction of the US figure for the same job title. That gap is why offshore delivery exists, but read it carefully. A salary is not a vendor rate: the price you pay also covers management, quality review, tooling, secure infrastructure, bench cover, training and margin. And a generic data analyst is not a pharma analyst who already knows what an NBRx is, how specialty pharmacy status codes behave or why an IQVIA prescriber file will not match your CRM without work.

Three practical cost rules follow:

• Compare on outputs, not day rates. Price the weekly report, the monthly IC run and the quarterly alignment refresh. A cheaper team that needs twice the review time from your managers is not cheaper.
• Count your own time. A managed service still needs an internal owner, typically a few hours a week once stable and much more during transition.
• Budget the transition separately. Documentation, parallel running and data access agreements cost money before any saving appears.

For the tooling side of the budget, our Power BI consultant cost guide covers what dashboard work typically costs.

A worked example: moving weekly reporting to a partner

The numbers here are illustrative, built from the benchmarks above to show the method, not a quote.

A specialty brand team runs four recurring outputs: a weekly field performance report, a weekly patient access and specialty pharmacy report, a monthly incentive compensation run and a quarterly territory alignment refresh. Today two in-house analysts produce them, mostly by hand in Excel, and spend most of each week on data preparation rather than analysis.

If those two analysts were paid the BLS median for market research analysts, their salaries alone would be about $157,520 a year, before benefits, recruitment and software. Outsourcing the production work does not remove that cost by itself. The saving comes in two steps:

1. Automate first. Before the work moves, the partner rebuilds the four outputs as automated pipelines and dashboards. In our own patient access reporting work for a specialty therapy provider, automation cut manual effort by 60 to 80 percent. Outsourcing a manual process just moves the manual work somewhere else.
2. Then move the run. The partner runs and checks the automated outputs to agreed service levels. The two internal analysts stop preparing data and start answering brand questions, which is the work you hired them for.

The honest result is usually not fewer people. It is the same headcount doing higher value work, with reporting delivered on time every week and a documented process that survives staff turnover.

Data access: the rule that stalls most outsourcing deals

Your commercial data is licensed, not owned, and the licences decide who may touch it. Syndicated data suppliers such as IQVIA generally require a third-party access agreement before any vendor can process their data on your behalf, and specialty pharmacy, hub and claims data contracts often carry their own restrictions on sharing and location. Patient-level data adds HIPAA, de-identification and Business Associate Agreement questions on top.

Sort this out before you sign with a partner, not after:

• List every data source the outsourced work touches, with the contract owner for each.
• Check which licences need a third-party access agreement, and how long the supplier takes to issue one.
• Decide where processing happens. The safest pattern is that the data never leaves your own cloud: the partner's team works inside your Snowflake, Databricks, Fabric or AWS environment under your access controls.
• Keep patient-level data de-identified or tokenised where you can. Our guide to patient tokenization in specialty pharma explains how.

A partner who says none of this applies to them has not done the work before.

How to choose a commercial analytics partner: the scorecard

• Pharma data fluency

  Ask them to explain how they match IQVIA or Veeva prescriber data to your CRM, and how they treat specialty pharmacy status codes. Generic analytics firms stumble here.

  • Named pharma data sources handled
  • HCP and HCO matching method
  • Examples of business rules they have built

• Automation before headcount

  A good partner proposes to automate your reports before staffing them. One that quotes analysts per report is pricing your manual process forever.

  • Pipelines, not spreadsheets
  • Documented logic
  • Fewer touches each month

• Works inside your environment

  The team should work in your cloud and your BI tools under your access controls, so the code, data and documentation stay yours.

  • No copies on vendor laptops
  • Your repository, your warehouse
  • Clean exit if you part ways

• Working-hours overlap

  India is nine and a half to ten and a half hours ahead of US Eastern time. Ask for named overlap hours with your team and what happens on a Monday morning deadline.

  • Daily overlap window agreed
  • Escalation path out of hours
  • Delivery times in your time zone

• Senior attention

  Ask who reviews the work and how often the senior person you met in the sales process will actually be involved after signing.

  • Named lead with pharma background
  • Review step before delivery
  • Same people at month six

• Exit terms

  You should be able to leave with your code, documentation and data, and a handover period written in. If exit is hard, quality tends to slide.

  • Code and docs owned by you
  • Handover period in contract
  • No proprietary lock-in

How to run the transition

SLAs to write into the contract, common mistakes and when not to outsource

Service levels worth measuring: on-time delivery of each scheduled output; data defects found after delivery; turnaround time for ad hoc requests by size; time to onboard a new data feed; and documentation kept current. Avoid contracts measured only on hours worked, which reward slow delivery.

Mistakes we see most often:

• Outsourcing before definitions are agreed, so the partner inherits three versions of the same KPI.
• Handing over manual spreadsheets and paying people to repeat them weekly.
• Signing before data licences allow the partner in, then waiting months for access.
• Removing the internal owner, so nobody can judge whether the output is right.
• Choosing on day rate alone and paying for it in review time.

When not to outsource: if your company is pre-launch with no stable data feeds, the work changes too often for a service to be efficient, and a short project to build the foundations is a better first step. If your reporting depends on a single expert's undocumented knowledge, document it before you move it. And if your volume is only a few reports a month, automating them may remove the need for a partner altogether.

Greenwolf Tech Labs is based in New Delhi with teams working US and European hours, and our founder Harsh Khubchandani spent his early career on specialty pharma commercial analytics at ZS Associates. We build the data foundation first, then run reporting on top of it. See our pharma commercial analytics service for scope, the specialty pharmacy analytics hub for patient services data, and related guides on pharma incentive compensation and the pharma commercial data warehouse.

Questions about outsourcing pharma analytics